Clinical trial
Phase IIb Study of Intranasal Glutathione in Parkinson's Disease
NCT02424708 is registered in ClinicalTrials.gov with Bastyr University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase IIb Study of Intranasal Glutathione in Parkinson's Disease
- Lead sponsor
- Bastyr University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 2015
- Completion date
- April 30, 2016
- Enrollment
- 45 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
parkinson's disease